Anika Therapeutics, Inc. (ANIK) — SC 13G/A Filings
All SC 13G/A filings from Anika Therapeutics, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Oct 23, 2024
- SC 13G/A Filing — Apr 5, 2024
-
Vanguard Trims Anika Therapeutics Stake to 8.7%
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Anika Therapeutics Inc. As of December -
Trigran Investments Amends Anika Therapeutics Stake
— Feb 9, 2024 Risk: low
Trigran Investments, Inc. filed an amended SC 13G/A on February 9, 2024, indicating their ownership of Anika Therapeutics, Inc. common stock as of December 31, -
Dimensional Fund Advisors Holds 8.0% Stake in Anika Therapeutics
— Feb 9, 2024 Risk: low
Dimensional Fund Advisors LP, a major investment firm, filed an amended SC 13G/A on February 9, 2024, indicating their ownership in Anika Therapeutics Inc. As o -
BlackRock Amends Anika Therapeutics Stake as of Dec 31, 2023
— Jan 24, 2024
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating a change in its ownership of Anika Therapeutics, Inc. common stock as of December 31, 2 -
State Street Corp Updates Anika Therapeutics Stake in SC 13G/A
— Jan 22, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Anika Therapeutics, Inc. common sto
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX